Claire Burton, MD
Urology · Glendora, CANPI 1841685401
Payments from drug & device makers
What this record shows
This record is dominated by grants: $13,346 of the $16,829 with a category attached, or 79.3%. Medtronic accounts for 84.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $10,239 and has fallen 93.4% since, to $678 in 2025.
Across 42 payments — averaging $400.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$14K
- Boston Scientific$2K
- Axonics, Inc.$590
- Bluewind Medical$185
- AbbVie$32
- Intuitive Surgical$24
What the payments were for
- Grants$13,34679%
- Food & beverage$3,48321%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 13 | $14,230 |
| Boston Scientific | 16 | $1,767 |
| Axonics, Inc. | 8 | $590 |
| Bluewind Medical | 3 | $185 |
| AbbVie | 1 | $32 |
| Intuitive Surgical | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$13,970
- Axonics$525
- GENERAL ERECTILE DYSFUNCTION$516
- Advantage System$274
- rezum Generator$173
- REVI$123
- Solyx SIS System$122
- GENERAL PELVIC ORGAN PROLAPSE$111
- AMS 700 CXR RTE KIT$110
- Bulkamid$107
How this compares
$16,829 in reported general payments places this provider in the 85th percentile of 1,324 urology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 181 | $118,640 |
| GemtesaVibegron | 171 | $112,011 |
| Estradiol | 361 | $24,704 |
| Trospium Chloride | 163 | $9,167 |
| Methenamine Hippurate | 90 | $7,359 |
| Trospium Chloride ErTrospium Chloride | 36 | $4,957 |
| YuvafemEstradiol | 17 | $2,544 |
| NitrofurantoinNitrofurantoin Macrocrystal | 22 | $1,617 |
| Trimethoprim | 11 | $872 |
| Hydroxyzine Hcl | 25 | $846 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 125 | $810 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 18 | $722 |
| Cephalexin | 81 | $687 |
| Finasteride | 23 | $362 |
| Solifenacin Succinate | 12 | $311 |
Paid to pharmacies, not to this prescriber.
Other urology in Glendora
- Stephen FreedlandWest Hollywood$1.9M
- Arie BelldegrunLos Angeles$1.8M
- Mihir DesaiLos Angeles$1.5M
- Steven WilsonIndio$1.1M
- Stuart HoldenLos Angeles$1.1M
- Elward CrawfordSan Diego$849K
- Edward UchioOrange$849K
- Victor ChingUpland$809K
- Jaime LandmanOrange$657K
- William AronsonLos Angeles$540K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.